Loading
Sentiment · FY2026 Q2
As of FY2026 Q1, the Tellvest earnings-call sentiment score for Zimmer Biomet (ZBH) is 9/10.
Zimmer Biomet delivered Q1 revenue growth of 9.3% reported and 2.9% organic constant currency with adjusted diluted EPS of $2.09 up from $1.81, raising EPS guidance to $8.40-$8.55 and free cash flow growth to 9-11%. The US salesforce transition progressed as planned while technology and robotics growth accelerated and Paragon 28 growth accelerated toward double digits. The CFO departure was announced and adjusted gross margin reached 73%, with $250M in share repurchases executed in Q1.
Scored from Zimmer Biomet’s FY2026 Q1 earnings call. The newest quarter is available with Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $2.02B | +4.3% | $1.20 | -40.3% | 71.0% | 19.2% | 11.8% | $421M |
| FY2025 Q1 | $1.91B | +1.1% | $0.91 | +8.3% | 71.2% | 15.3% | 9.5% | $336M |
| FY2025 Q2 | $2.08B | +7.0% | $0.77 | -34.7% | 71.5% | 14.4% | 7.4% | $298M |
| FY2025 Q3 | $2.00B | +9.7% | $1.16 | -5.7% | 72.1% | 17.6% | 11.5% | $546M |
| FY2025 Q4 | $2.24B | +10.9% | $0.70 | -41.7% | 64.7% | 12.8% | 6.2% | $669M |
| FY2026 Q1 | $2.09B | +9.3% | $1.22 | +34.1% | 72.4% | 17.9% | 11.4% | $323M |
| FY2026 Q2 | $2.18B | +4.8% | $1.03 | +33.8% | 70.8% | 15.0% | 9.1% | $484M |